Purchase order NNX17CL66PHUMANETICS CORPORATION
Overview
Award facts
- Net obligations
- $124.69K
- $124,693of $124.69K potential value
- Period of performance
- Jun 9, 2017 to Dec 8, 2017
- Ended
- Modifications
- 0
- Latest action Jun 6, 2017
- Contract type
- Purchase order
- PIID NNX17CL66P
Description of requirement
IGF::OT::IGF THE CUMULATIVE DOSE OF RADIATION EXPOSURE TO OUR ASTRONAUTS REMAINS ONE OF THE LIMITING ROADBLOCKS TO LONGER DURATION MISSIONS IN SPACE. HUMANETICS CORPORATION (HUMANETICS) IS DEVELOPING A NOVEL RADIOPROTECTANT, BIO 300, FOR USE IN BOTH CLINICAL RADIOTHERAPY AND AS A RADIATION COUNTERMEASURE. BIO 300 IS A SAFE, SHELF-STABLE PHARMACEUTICAL WHICH HAS BEEN SHOWN TO MITIGATE BOTH THE ACUTE AND DELAYED EFFECTS OF RADIATION EXPOSURE. BIO 300 IS IN ADVANCED STAGES OF CLINICAL DEVELOPMENT, AND IS CURRENTLY BEING EVALUATED AS A RADIOPROTECTANT OF HEALTHY LUNG TISSUE DURING RADIOTHERAPY TREATMENT FOR NON-SMALL CELL LUNG CANCER IN A PHASE I/II TRIAL. ONE COMPONENT OF DEVELOPING RADIOPROTECTANTS FOR SPACE IS UNDERSTANDING IF THE THERAPY CAN PROTECT AGAINST BROAD-SPECTRUMS OF IONIZING RADIATION, RATHER THAN JUST MAN-MADE X-RAYS. THUS, THE OBJECTIVE OF THIS PROPOSAL IS TO EXAMINE BIO 300'S RADIOPROTECTIVE CAPABILITIES AGAINST MISSION-RELEVANT DOSES OF NEUTRON/GAMMA MIXED-FIELDS OF RADIATION. ANOTHER COMPONENT OF THE WORK PROPOSED HERE, IS TO UTILIZE A NOVEL CELLULAR PLATFORM OF TERMINALLY DIFFERENTIATED HUMAN CARDIOMYOCYTES TO INVESTIGATE DEGENERATIVE CONSEQUENCES OF RADIATION EXPOSURE IN A FUNCTIONAL HUMAN TISSUE MODEL. TOGETHER, THESE STUDIES WILL VALIDATE THE UTILITY OF BIO 300 AS A COUNTERMEASURE FOR EXTRATERRESTRIAL RADIATION EXPOSURES.
Dates and value
- Award date
- Signed on Jun 6, 2017
- Potential end of performance
- Dec 7, 2017
- Current value
- $124,693Base and exercised options
- Potential value (if all options are exercised)
- $124,693
Obligations by fiscal year of action
- FY2017: $124,693
Total across 1 fiscal year: $124,693
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 6, 2017. View on USAspending · Recipient on SAM.gov
Recipient
Business types and certifications
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- National Aeronautics and Space Administration
- NASA SHARED SERVICES CENTER
- Funded by
- National Aeronautics and Space Administration
- NASA SHARED SERVICES CENTER
- Funded from
- Space technology (DIRECT)Program activities080-0131Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Minneapolis, Hennepin County, Minnesota 55435-6012
- Congressional district (place of performance)
- MN-03As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AR11R&D- SPACE: AERONAUTICS/SPACE TECHNOLOGY (BASIC RESEARCH) (research and development)
Competition
- Extent competed
- Full and open competition after exclusion of sourcesD
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- Small business set aside - totalSBA
- Contract pricing
- Firm fixed priceJ
- Offers received
- 500
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Protecting cardiomyocytes from mixed fields of radiation by bio 300
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial item procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jun 6, 2017Base obligation at award: $124,693
- Latest action
- Jun 6, 2017 — Base awardModification 0; obligation change +$124,693
- Actions by type
- Base award1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $124,693
- Latest action: change in base and all options
- $124,693
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Research program (SBIR/STTR)
- Small business innovation research program phase i actionSR1
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 8000
- Awarding sub-tier code
- 8000
- Contracting office code
- 80NSSC
- Transactions recorded under this award key
- 1
Funding
- Funding agency code
- 8000
- Funding sub-tier code
- 8000
- Funding office code
- 80NSSC
- Treasury accounts
- 080-2017/2018-0131-000
- Object classes
- 25.5: Research and development contracts